AC Immune SA ACIU
NASDAQ
| 06/30/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -17.99M | -19.82M | -25.69M | -21.17M |
| Total Depreciation and Amortization | -- | 819.90K | 766.30K | 755.20K | 680.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 1.26M | 87.50K | 3.01M | 2.11M |
| Change in Net Operating Assets | -- | -4.75M | -3.96M | 3.01M | -2.55M |
| Cash from Operations | -- | -20.66M | -22.93M | -18.91M | -20.93M |
| Capital Expenditure | -- | -133.90K | -72.50K | -452.20K | -402.70K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 18.20K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 20.17M | 25.86M | 29.39M | 3.77M |
| Cash from Investing | -- | 20.03M | 25.79M | 28.95M | 3.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -260.00K | -258.00K | -255.00K | -253.00K |
| Issuance of Common Stock | -- | -- | 4.00K | 3.00K | -- |
| Repurchase of Common Stock | -- | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 5.00K | -5.00K |
| Cash from Financing | -- | -326.70K | -317.50K | -299.40K | -287.00K |
| Foreign Exchange rate Adjustments | -- | -225.30K | -18.80K | -2.76M | -299.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -1.18M | 2.52M | 6.99M | -18.15M |